Aroa Biosurgery has successfully raised additional capital from new and existing investors from the USA, Australia and New Zealand.
Aroa Biosurgery has successfully raised additional capital from new and existing investors from the USA, Australia and New Zealand.
The company will use the additional capital raised to fund the company’s growth activities. These activities will include:
- Development of the company’s pipeline of new tissue regeneration products using its proprietary Endoform® platform technology.
- Development of the company’s proprietary processes (including tissue processing and fabrication technology).
- Scaling-up operations and general corporate purposes.
The company is appreciative of the continued support of its existing shareholders, and is excited to be able to attract new high calibre institutional investors in this latest capital raising round.
